Phase I, Study in Chinese NSCLC Patients

Trial Identifier:	D5160C00018
Sponsor:	AstraZeneca
NCTID::	NCT02529995
Start Date:	August 2015
Primary Completion Date:	January 2016
Study Completion Date:	September 2019
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Guangzhou, China, 510060
China	Hangzhou, China, 310003
China	Shanghai, China, 200032

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.